75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Equity Method Investment link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Loan with Silicon Valley Bank, a Division of First Citizens Bank link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Einstein License Agreement link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Collaboration Revenue link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Cue Biopharma 401(k) Plan link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Fair Value (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Loan with Silicon Valley Bank, a Division of First Citizens Bank (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Collaboration Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Warrants (Table) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Organization and Basis of Presentation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Fair Value - Schedule of Fair Value Assets Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Fair Value - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Marketable Securities - Schedule of Fair Value of Available-for-Sale Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Property and Equipment, Net - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Property and Equipment, Net - Summary of Depreciation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Equity Method Investment (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Loan with Silicon Valley Bank, a Division of First Citizens Bank - Summary of Future Principal Debt Payments on Term Loan Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Loan with Silicon Valley Bank, a Division of First Citizens Bank - Summary of Future Principal Debt Payments on Term Loan Agreement (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Loan with Silicon Valley Bank, a Division of First Citizens Bank (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Einstein License Agreement - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Stock-based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Stock-based Compensation - Schedule of Estimated Fair Value of Each Stock Option Award (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Stock-based Compensation - Schedule of Nonvested Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Stock-based Compensation - Schedule of Stock-Based Compensation Included in Statement of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Warrants - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Warrants - Summary of Common Stock Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Collaboration Revenue - Schedule of Collaboration Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Collaboration Revenue - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Stockholders' Equity - Schedule of Number of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Income Taxes Income Taxes - Schedule of Components of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Income Taxes Income Taxes - Schedule of Reconciliation of Federal Statutory Rate and Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Income Taxes Income Taxes - Schedule of Reconciliation of Gross Uncertain Tax Position (Details) link:presentationLink link:calculationLink link:definitionLink 996115 - Disclosure - Income Taxes - Summary of the Company's income taxes paid (net of refunds received) (Details) link:presentationLink link:calculationLink link:definitionLink 996125 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996135 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996145 - Disclosure - Leases - Schedule of Future Minimum Lease Payments on Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 996155 - Disclosure - Leases - Schedule of Future Minimum Lease Payments on Operating Leases (Details) 2 link:presentationLink link:calculationLink link:definitionLink 996165 - Disclosure - Lease - Schedule of Other Information of Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 996175 - Disclosure - Cue Biopharma 401(k) Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996185 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Weighted Average Grant Date Fair Value Per Share, Vested/Released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Disposal of Gross Assets Proceeds from Sale of Property, Plant, and Equipment Proceeds from Sale of Property, Plant, and Equipment, Total Cash received from the sale of property and equipment Employee and board compensation Accrued Employee Benefits, Current Sales Agreement June 2020 Agreement4 [Member] Agreement four member. Trademark Trademark Policy [Text Block] Trademark. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Preferred Stock, Shares Issued, Total Preferred stock, shares issued Preferred Stock, Shares Issued Company Contribution Defined Benefit Plan, Plan Assets, Contributions by Employer Effective Income Tax Rate Reconciliation, Tax Credit, Amount [Abstract] Tax Credits: Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accounts Payable Plan Name Plan Name [Axis] Entity Current Reporting Status Entity Current Reporting Status Operating Expenses [Abstract] Operating expenses (income): Level 2 Fair Value, Inputs, Level 2 [Member] Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Operating Leases Rent Expenses Net Operating Leases Rent Expenses Net Operating Leases, Rent Expense, Net Common stock, shares authorized Common Stock, Shares Authorized Cambridge, Massachusetts MASSACHUSETTS Percentage Increase in Lease Agreement Amount Percentage Increase in Lease Agreement Amount Percentage Increase in Lease Agreement Amount Product and Service [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Long-Duration Contracts, Assumptions by Product and Guarantee, Estimated Average Investment Yield Dividend Yeild Revenue from Contract with Customer [Abstract] Entity Shell Company Entity Shell Company Prepayment premium rate Prepayment premium rate Prepayment Premium Rate Aggregate amount of additional milestone payments Aggregate Amount Of Additional Milestone Payments Maximum Aggregate amount of a one-time additional milestone payments based on cumulative sales of all licensed products, maximum. February2020 Awarded And Granted February2020 Awarded And Granted [Member] February 2020 awarded and granted. Payment for Other Operating Activity Payment for License Agreement Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalent Schedule of Maturities of Long-Term Debt [Table Text Block] Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate Volatility Rate Effective Income Tax Rate Reconciliation Foreign Tax Effects Percent [Abstract] Effective Income Tax Rate Reconciliation Foreign Tax Effects Percent [Abstract] Foreign Tax Effects: Research and Development Arrangement, Contract to Perform for Others, Type [Axis] License monthly rental rate License monthly rental rate License monthly rental rate Cybersecurity Risk Management, Strategy, and Governance [Abstract] Common Stock, Shares, Issued, Total Common stock, shares issued Common Stock, Shares, Issued Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Cybersecurity Risk Board of Directors Oversight [Text Block] Warrant Issued December Twenty Seven Two Thousand Seventeen Member Warrant Issued December Twenty Seven Two Thousand Seventeen [Member] Warrant Issued December 27, 2017 Pre-Funded Warrants [Member] Pre-Funded Warrants [Member] Pre-Funded Warrants Statement [Table] Statement [Table] Upfront Payment Upfront Payment Upfront Payment Restricted cash Restricted Cash, Noncurrent Term Loan Agreement [Member] Term Loan Agreement Member Additions for current year tax provisions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Deposits Increase Decrease In Deposit Liabilities Increase decrease in deposit liabilities. Noninterest Expense Commission Expense Commissions and offering expenses Proceeds from sale of common stock Proceeds From Sale Of Common Stock Net Commission Paid1 ProceedsFromSaleOfCommonStockNetCommissionPaid. Proceeds from Debt, Net of Issuance Costs Issuance of common stock upon exercise of warrants and pre-funded warrants, net On December Ninteen Two Thousand Twenty Five [Member] On December Ninteen Two Thousand Twenty Five [Member] On December 19, 2025 [Member] Statement [Line Items] Statement [Line Items] Warrant [Member] Common Stock Warrants [Member] Warrant Entity Filer Category Entity Filer Category Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Debt Issuance Costs, Gross, Current Less: unamortized debt issuance costs Less: unamortized debt issuance costs Total liabilities and stockholders’ equity Liabilities and Equity Lessee Operating Lease Monthly Rental Payments For Second Year Lessee Operating Lease Monthly Rental Payments For Second Year Payments to Acquire Marketable Securities Purchases of marketable securities Long-Term Debt, Maturity, Year Three 2025 Weighed Average Exercise Price, Exercisable Weighed Average Exercise Price, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Public Offerings and Private Placement Public Offerings and Private Placement Policy Text Block Public Offerings and Private Placement [Policy Text Block] Operating lease agreement for additional laboratory space. Operating Lease Agreement For Additional Laboratory Space [Member] Operating Lease Agreement For Additional Laboratory Space Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Adjustment related to right of use asset Adjustment Related To Right Of Use Asset Adjustment related to right of use asset Deferred Revenue [Domain] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Deferred Tax Assets, Valuation Allowance, Total Less valuation allowance Deferred Tax Assets, Valuation Allowance U. S. federal statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent U. S. federal statutory tax rate Offering price of shares Shares Issued, Price Per Share Subsequent Event [Line Items] Two Thousand Twenty Four Common Stock Warrants [Member] Two Thousand Twenty Four Common Stock Warrants [Member] 2024 Common Stock Warrants Lease agreement effective date Lease Agreement Effective Date Lease agreement effective date. Cybersecurity Risk Management Third Party Engaged [Flag] Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Boston [Member] Boston [Member] Boston [Member] Full time employe salary payable in first research term Full time employe salary payable in first research term Full time employe salary payable in first research term Effective Income Tax Rate Reconciliation, Percent Total Income Tax Authority Income Tax Jurisdiction [Axis] Capitalized costs incurred Capitalized Costs Incurred Capitalized costs incurred. Geographical Geographical [Domain] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Foreign Tax Effects: Effective Income Tax Rate Reconciliation Foreign Tax Effects Amount [Abstract] Effective Income Tax Rate Reconciliation Foreign Tax Effects Amount [Abstract] Securities Financing Transaction Securities Financing Transaction [Axis] Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional paid in capital Additional Paid in Capital, Common Stock Income Taxes Paid Percent Income Taxes Paid Percent Income taxes paid Debt Issuance Costs, Net, Total Debt Issuance Costs, Net Debt Issuance Costs, Net, Total Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Issuance of Common Stock Warrants and Pre Funded Warrants Net Of Issuance Costs Amount Issuance of common stock, warrants and pre-funded warrants, net of issuance costs amount. Issuance of common stock, warrants and pre-funded warrants, net of issuance costs, Amount Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and contingencies. Number of shares, granted Stock option granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Cybersecurity Risk Management, Strategy, and Governance [Table] Collaboration and License Agreement with ImmunoScape Pte Ltd [Member] Collaboration and License Agreement with ImmunoScape Pte Ltd [Member] Collaboration and License Agreement with ImmunoScape Pte Ltd Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract] Nontaxable or Nondeductible Items: Laboratory Equipment Laboratory Equipment [Member] Laboratory equipment. Investment, Name [Axis] Earnings Per Share, Basic, Total Earnings Per Share, Basic Net loss per common share - basic Summary of Depreciation Expense Summary Of Depreciation Expense Table [Text Block] Summary of depreciation expense. Lease agreement description Description of Lessee Leasing Arrangements, Operating Leases Number of Shares, Outstanding Beginning Balance Number of Shares, Outstanding Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Licensed Products [Member] Licensed products. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property (Gain) loss on fixed asset disposal Loss (gain) on fixed asset disposal Loss (gain) on fixed asset disposal Debt, Policy [Policy Text Block] Debt Issuance Costs Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage Unencumbered cash amount equal lesser, percentage Interest Income (Expense), Nonoperating Interest income Total current liabilities Liabilities, Current Debt Securities, Held-to-Maturity, Threshold Period Past Due Marketable securities, Maturity period Debt Issuance Costs [Member] Debt Issuance Costs [Member] Debt Issuance Costs [Member] Increase (Decrease) in Accounts Receivable Accounts receivable Lease modification date Lease Modification Date Lease modification date. Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Issuance of common stock from ATM offering, net of sales agent commission and fees, Shares Issuance of common stock from ATM offering, net of sales agent commission and fees, Shares Income Tax Paid, Federal Income Tax Paid, Federal, after Refund Received Income Tax Paid, Federal, after Refund Received, Total OneTimeUpFrontPaymentPayableAsConsiderationRDActivities One Time Up Front Payment Payable As Consideration RD Activities One time up front payment payable as consideration rd activities Federal Domestic Tax Jurisdiction [Member] Effective Income Tax Rate Reconciliation, Tax Credit, Percent [Abstract] Tax Credits: Sales Agreement October 2021 Agreement2 [Member] Agreement 2 member. Transaction Expense Transaction Expense [Member] Transaction expense. Total Receive Upfront Payments Total Receive Upfront Payments Effective Income Tax Rate Reconciliation [Table] Additions for prior year tax provisions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Accounting Standards Update Accounting Standards Update [Axis] Risk-Free Rate Long-Duration Contracts, Assumptions by Product and Guarantee, Risk-Free Rate Long-Duration Contracts, Assumptions by Product and Guarantee, Risk-Free Rate Stockholders’ equity: Equity, Attributable to Parent [Abstract] Foreign withholding tax receivable Foreign withholding tax receivable Foreign withholding tax receivable Entity Small Business Entity Small Business Net operating losses indefinite carryforward amount Net Operating Losses Indefinite Carryforward Amount Net operating losses indefinite carryforward amount. Increase (Decrease) in Accrued Liabilities, Total Accrued expenses Increase (Decrease) in Accrued Liabilities Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Retained Earnings (Accumulated Deficit) Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Stock-based compensation Foreign withholding tax receivable Value Added Tax Receivable, Current First Amendment First Amendment to Merck First Amendment [Member] ASU 2016-02 Accounting Standards Update 2016-02 [Member] Additional Common Stock Warrant Purchases Common Shares Additional Common Stock Warrant Purchases Common Shares Additional common stock warrant purchases common shares Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Leases beginning date Operations Commenced Date Number of Shares, Cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Einstein License Agreement Einstein License Agreement [Member] Einstein license agreement. Proceeds from Issuance Initial Public Offering Proceeds from Issuance Initial Public Offering Sale of Stock, Price Per Share Sale of Stock Price Per Share Warrant Issued Warrant Issued Issued Lessee operating lease monthly rental payments for first twelve months Lessee Operating Lease Monthly Rental Payments For First Twelve Months Lessee operating lease monthly rental payments for first twelve months. Restricted Stock Award, Forfeitures, Total Repurchase of restricted stock awards Restricted Stock Award, Forfeitures Type of Cost, Good or Service [Extensible List] Cost, Product and Service [Extensible Enumeration] COVID 19 Pandemic Covid19 Pandemic Policy [Text Block] Disclosure of accounting policy for Covid 19 pandemic. Organization, Consolidation and Presentation of Financial Statements [Abstract] Proceeds from sale of common stock Proceeds From Sale Of Common Stock Net Commission Paid Proceeds from sale of common stock net commission paid. Defined Contribution Plan [Table] Defined Contribution Plan [Table] 401(k) Plan Four Hundred One K Plan [Member] 401 k Plan . Lease Contractual Term Lease Contractual Term [Axis] Leases [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures [Abstract] ImmunoScape Pte. Ltd. ImmunoScape Pte Ltd [Member] ImmunoScape Pte Ltd [Member] Lessee, Lease, Description [Line Items] Amendment Flag Amendment Flag Product and Service [Domain] Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount US Federal Statutory Tax Rate Class of Warrant or Right, Number of Securities Called by Warrants or Rights Purchase of Additional Shares of Common Stock Finance Lease, Interest Expense Finance Lease, Interest Expense Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Oppenheimer & Co. Inc. [Member] Oppenheimer & Co. Inc. [Member] Oppenheimer & Co. Inc. Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cue Biopharma 401(k) Plan [Member] Cue Biopharma 401(k) Plan [Member] Common Stock [Member] Common Stock [Member] Common Stock Cybersecurity Risk Role of Management [Text Block] Tax credits Tax Credit Carryforward, Amount 2024 Long-Term Debt, Maturity, Year One Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Development and commercialization right percentage Development and commercialization right percentage Lessee, Operating Lease, Liability, to be Paid, Year Three 2028 Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less accumulated depreciation Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Income Taxes [Table] Income Taxes [Table] Income taxes. Amortization of premium/discount on purchased securities Amortization of Debt Discount (Premium) Schedule Of Available For Sale Securities [Line Items] Debt Securities, Available-for-Sale [Line Items] Intrinsic value of exercisable fair value per share Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Exercisable Intrinsic Fair Value Per Share Share based compensation arrangement by share based payment award fair value of options exercisable intrinsic fair value per share. Income Tax Paid, by Individual Jurisdiction [Line Items] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Address, Address Line One Entity Address, Address Line One Depreciation Deferred Tax Liabilities Depreciation Deferred tax liabilities depreciation. Schedule of Estimated Fair Value of Each Stock Option Award Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Level 2 Fair Value Hierarchy and NAV [Axis] Income Taxes Income Tax, Policy [Policy Text Block] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Supplemental Cash Flow Information [Abstract] Supplemental disclosures of non-cash investing and financing activities: License monthly rental rate second year License monthly rental rate second year License monthly rental rate second year Tax credits carryforward expiration start year Tax Credit Carryforward Expiration Start Year Tax credit carryforward expiration start year. Warrants Issued December Two Thousand Twenty Five [Member] Warrants Issued December Two Thousand Twenty Five [Member] Warrants Issued December, 2025 [Member] Payments for Underwriting Expense Commissions and offering expenses Operating lease right-of-use assets Operating lease, right-of-use asset Operating Lease, Right-of-Use Asset Approximately Received of Upfront Payments Approximately Received of Upfront Payments Approximately Received of Upfront Payments Total gross deferred tax assets Deferred Tax Assets, Gross Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Unrealized loss from available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Document Type Document Type Original exercise price at issuance Original Exercise Price Of Warrants Original Exercise Price Of Warrants Income Taxes Paid Income Taxes Paid, Net Total Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Equity, Fair Value Disclosure Equity, Fair Value Disclosure, Total Fair value of equity interest Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Entity Central Index Key Schedule of Fair Value of Available-for-Sale Marketable Securities Debt Securities, Available-for-Sale [Table Text Block] Investments, Debt and Equity Securities [Abstract] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Summary of Estimated Useful Lives of Assets Estimated Useful Lives Of Assets Table [Text Block] Estimated useful lives of assets. Valuation Approach and Technique [Axis] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net increase (decrease) in cash, cash equivalents, and restricted cash Subsequent Event Type [Domain] Fair value of shares and warrants received pursuant to Collaboration and License Agreement with IMSCP Fair Value Adjustment of Warrants Antidilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount LG Chem Life Sciences L G Chem Life Sciences [Member] LG Chem Life Sciences. Common stock, par value Common Stock, Par or Stated Value Per Share Accounting Standards Update Accounting Standards Update [Domain] Percentage of Debt Hedged by Interest Rate Derivatives Silicon Valley Bank [Member] Silicon Valley Bank [Member] Silicon Valley Bank Stock based payment options outstanding weighted average remaining term Weighted Average Remaining Contractual Life (in Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Marketable securities of investments Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Marketable securities Debt Securities, Available-for-sale, Total Fair Value Debt Securities, Available-for-Sale Warrant Issued September Twenty Six Two Thousand Twenty Four [Member] Warrant Issued September Twenty Six Two Thousand Twenty Four [Member] Warrant Issued September 26, 2024 Document Financial Statement Error Correction [Flag] Debt Instruments [Abstract] Number of Shares, Exercised Exercise of stock options, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Debt Disclosure [Abstract] Milestone payments received Milestone Payments Received Milestone payments received. Two Thousand Twenty Five Pre Funded Warrants [Member] Two Thousand Twenty Five Pre Funded Warrants [Member] 2025 Pre-funded warrants [Member] Marketable Securities Marketable Securities, Total Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary of significant accounting policies. Accrued expenses Accrued Liabilities, Current Total Restricted stock awards Stock Issued During Period, Value, Restricted Stock Award, Gross Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Schedule of Long-Term Debt Instruments [Table] Placement Fees Placement Fees Placement fees Restricted Cash and Cash Equivalents Restricted Cash and Cash Equivalents [Axis] Other payable Increase Decrease In Other Payable Increase Decrease In Other Payable Lab Space Lease Member Lab Space Lease [Member] Additional Laboratory Lease Third Amendment Additional Laboratory Lease Third Amendment [Member] Additional laboratory lease third amendment member. Einstein Einstein [Member] Einstein. Entity Address, State or Province Entity Address, State or Province Unvested share purchase Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, Nonvested balance as of December 31, 2021 Number of Shares, Nonvested balance at December 31, 2022 Issuance of Common Stock Warrants and Pre Funded Warrants Net of Issuance Costs Issuance of common stock, warrants and pre-funded warrants, net of issuance costs Issuance of common stock, warrants and pre-funded warrants, net of issuance costs, Shares Investment, Name [Domain] Lessee operating lease monthly rental payments for remaining term Lessee Operating Lease Monthly Rental Payments For Remaining Term Lessee operating lease monthly rental payments for remaining term. Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Percentage of right to development and commercialized Percentage of right to development and commercialized Percentage of right to development and commercialized Two Thousand Twenty Five Common Stock Warrants [Member] Two Thousand Twenty Five Common Stock Warrants [Member] 2025 Common Stock Warrants Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Common stock reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Geographical Geographical [Axis] Line of Credit Facility, Lender [Domain] Warrants Issued April Two Thousand Twenty Five [Member] Warrants Issued April Two Thousand Twenty Five [Member] Warrants Issued April, 2025 [Member] Jefferies LLC Jefferies LLC [Member] Jefferies LLC Warrants Warrants [Text Block] Warrants. Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Schedule of Components of Deferred Tax Assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Operating loss carryforwards expiration start year Operating Loss Carryforwards Expiration Start Year Operating loss carryforwards expiration start year. 2022 Pre-Funded Warrants and 2022 Common Stock Warrants Two Thousand Twenty Two Common Stock Warrants and Two Thousand Twenty Two Pre-Funded Warrants [Member] Two Thousand Twenty Two Common Stock Warrants and Two Thousand Twenty Two Pre-Funded Warrants [Member] Collaborative Arrangement Disclosure [Text Block] Einstein License Agreement Stock Option Equity Option [Member] Lessee operating lease monthly rental payments Lessee Operating Lease Monthly Rental Payments Amount of cash outflow of lessee operating lease monthly rental payments. Two Thousand Twenty Two Common Stock Warrants and Two Thousand Twenty Four Pre-Funded Warrants [Member] Two Thousand Twenty Two Common Stock Warrants and Two Thousand Twenty Four Pre-Funded Warrants [Member] 2022 Common Stock Warrants and 2022 Pre-Funded Warrants Subsequent Event [Member] Marketable Securities Marketable Securities, Policy [Policy Text Block] Number of supporting technologies Number Of Supporting Technologies Under License Agreement Number of supporting technologies under license agreement. Property, Plant and Equipment [Abstract] Number of additional shares authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Nonrefundable milestone payments Nonrefundable Milestone Payments Nonrefundable milestone payments. Other Assets, Noncurrent, Total Other long-term assets Other long term assets Other Assets, Noncurrent Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Less: unamortized debt issuance costs Less: unamortized debt issuance costs Unamortized issuance costs Debt Securities, Available-for-sale, Current, Total Marketable securities Debt Securities, Available-for-Sale, Current Marketable securities Deferred Revenue Arrangement Type [Axis] 2016 Non-Employee Equity Incentive Plan Two Thousand Sixteen Non Employee Equity Incentive Plan [Member] Two thousand sixteen non-employee equity incentive plan. Antidilutive Securities Antidilutive Securities [Axis] Combined price of share Warrant, Exercise Price, Decrease Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Expired Expired Income Tax Paid, Foreign Income Tax Paid, Foreign, after Refund Received Income Tax Paid, Foreign, after Refund Received, Total State State and Local Jurisdiction [Member] Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of Stock-Based Compensation Included in Statement of Operations Related Party Transaction [Axis] Accumulated Other Comprehensive Gain AOCI Attributable to Parent [Member] Lease monthly rental payments Lease Monthly Rental Payments Lease monthly rental payments. Interest rate Debt Instrument, Interest Rate, Basis for Effective Rate Cash and Cash Equivalents Cash and Cash Equivalents [Domain] Lessee, Operating Lease, Option to Extend Extension of lease term Warrants Issued November Two Thousand Twenty Two [Member] Warrants Issued November Two Thousand Twenty Two [Member] Warrants Issued November, 2022 [Member] Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Preferred stock, $0.001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding at December 31, 2025 and December 31, 2024 Fair value of option Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Market Close Price Share based compensation arrangement by share based payment award fair value of options at market close price. Minimum [Member] Minimum Weighted average grant date fair value per share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Financial Instrument Financial Instrument [Axis] Current assets: Assets, Current [Abstract] Interest Expense, Other Interest expense, Other Amortization of Intangible Assets, Total Amortization of Intangible Assets Amortization related to trademark Amortization of Intangible Assets Milestone Fees Milestone Fees Level 3 Fair Value, Inputs, Level 3 [Member] Segment Information [Abstract] Schedule of Fair Value Assets Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Unrealized Gain (Loss) on Investments, Total Unrealized gain on investments Unrealized Gain (Loss) on Investments Long-term research and development contract liability Research and development contract liability, net of current portion Research And Development Contract Liability Noncurrent Research and development contract liability, noncurrent. Current liabilities: Liabilities, Current [Abstract] Sales Agreement March 2020 Agreement3 [Member] Agreement three member. Related Party Transactions [Abstract] Additional Laboratory Lease Fourth Amendment [Member] Additional Laboratory Lease Fourth Amendment [Member] Additional Laboratory Lease Fourth Amendment Member Balance, Shares Balance, Shares Shares, Outstanding Operating Loss Carryforwards, Total Operating loss carryforwards Operating Loss Carryforwards Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Cash obligation percentage Cash obligation percentage Cash obligation percentage Commitments and Contingencies Commitments and contingencies (Note 14) Leases Lessee, Leases [Policy Text Block] Unvested weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Per Share, Nonvested balance at December 31, 2022 Weighted Average Grant Date Fair Value Per Share, Nonvested balance as of December 31, 2021 Cash Concentrations Cash Concentration Policy [Text Block] Cash Concentration Policy [Policy Text Block] Shareholders' Equity and Share-Based Payments [Text Block] Stock-based compensation Other Short-Term Borrowings Remaining short term loan General and Administrative Expense General and Administrative Expense [Member] Recent Accounting Pronouncements Not Yet Adopted [Policy Text Block] Recent Accounting Pronouncements Not Yet Adopted [Policy Text Block] Recent Accounting Pronouncements Not Yet Adopted Operating Lease, Liability, Total Operating lease, liability Present value of lease payments Operating Lease, Liability Auditor Firm ID Debt Instrument, Basis Spread on Variable Rate Debt Instrument, Basis Spread on Variable Rate Short-Term Debt, Total Short-Term Debt Short-Term Debt Short-Term Lease Commitment, Amount Short term operating lease obligation Time to Liquidity Event Time to Liquidity Event Time to liquidity event Nonvested Restricted Stock Units Nonvested Restricted Stock Units [Member] Nonvested restricted stock units. 2025 Long-Term Debt, Maturity, Year Two Operating expenses Operating Expense [Member] Lessee, Lease, Description [Table] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance Interest Income (Expense), Net, Total Interest Income (Expense), Operating Interest expense Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Lease Contractual Term Lease Contractual Term [Domain] Other Loans Payable, Current Other current payable Up front non refundable payment Up Front Non Refundable Payment Up front non refundable payment. Long-Term Debt, Type [Domain] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted average common shares outstanding, basic Intrinsic value of exercisable stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value TwoThousandTwentyFivePre-FundedWarrantsMember TwoThousandTwentyFivePre-FundedWarrantsMember 2025 Pre-Funded Warrants Schedule of Reconciliation of Federal Statutory Rate and Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Milestone payments for each new indication of licensed product Aggregate Amount Of Milestone Payments For Each New Indication Of Licensed Product Maximum Aggregate amount of milestone payments for each new indication of licensed product, maximum. Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Two Thousand Sixteen Omnibus Incentive Plan Two Thousand Sixteen Omnibus Incentive Plan [Member] Two thousand sixteen omnibus incentive plan. Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Stock options granted purchase shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Subsequent Events Subsequent Events [Text Block] Deferred tax assets valuation allowance percentage. Deferred Tax Assets Valuation Allowance Percentage Percentage of valuation allowance against deferred tax assets Percentage Of Cash Deposited Percentage Of Cash Deposited Percentage of cash and cash equivalents deposited Related Party Transactions Related Party Transactions Disclosure [Text Block] APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Deferred Tax Asset, In-Process Research and Development R&D capitalization Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Pretax Loss Effective Income Tax Rate Reconciliation Income Tax Rate Pretax Loss Amount Effective Income Tax Rate Reconciliation Income Tax Rate Pretax Loss Amount Total stockholders’ equity Balance Balance Equity, Attributable to Parent Merck Merck [Member] Merck. Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Company Paid Collaboration And License Agreements Fees Company Paid Collaboration And License Agreements Fees Company paid collaboration and license agreements fees Increase in security deposit Increase in security deposit Increase in security deposit Statement of Stockholders' Equity [Abstract] Available For Debt Securities Available For Debt Securities Marketable securities Valuation Approach and Technique [Domain] Use of Estimates Use of Estimates, Policy [Policy Text Block] Equity Method Investment [Table] Operating Lease Agreement Operating Lease Agreement [Member] Operating lease agreement. Overallotment option Over-Allotment Option [Member] Leasehold-Improvements Leasehold Improvements [Member] Fair Value Fair Value Disclosures [Text Block] Offering expenses Offering expenses Offering expenses Investment, Fair Value Investment Owned, Fair Value Investment Owned, Fair Value, Ending Balance Investment Owned, Fair Value, Beginning Balance Warrants and Rights Note Disclosure [Abstract] Summary of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Debt Instrument, Name [Domain] Schedule of Reconciliation of Gross Uncertain Tax Position Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] March2020 Awarded And Granted March2020 Awarded And Granted [Member] March 2020 awarded and granted. IPR&D Member In Process Research and Development [Member] Plan Name Plan Name [Domain] Interest Expense, Total Interest Expense, Operating and Nonoperating Interest expense Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Lessee Operating Lease Monthly Rental Payments For Third Year Lessee Operating Lease Monthly Rental Payments For Third Year Equity Method Investment, Ownership Percentage Percenatage of equity issued and outstanding Licensing Fees and Costs Licensing Fees And Costs Policy [Text Block] Licensing fees and costs. Patent expenses Costs incurred Cost of Goods and Services Sold, Total Cost of Product and Service Sold Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Stock Issued During Period, Value, Other Issuance of common stock and pre-funded warrants, net of issuance costs Two Thousand Twenty Two Pre-Funded Warrants [Member] Two Thousand Twenty Two Pre-Funded Warrants [Member] 2022 Pre-Funded Warrants Organization and Basis of Presentation Business Description and Basis of Presentation [Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Certificate of Deposit Certificates of Deposit [Member] Contract manufacturing services Accrued Contract Manufacturing Services Current Accrued contract manufacturing services current. Twenty one erie laboratory and office lease. Twenty One Erie Laboratory and Office Lease [Member] Common stock warrants outstanding Class of Warrant or Right, Outstanding Balance at December 31, 2025 Balance at December 31, 2024 Related and Nonrelated Parties [Axis] General Partners' Cumulative Cash Distributions Consolidated aggregate cash Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Class Of Warrant Or Right [Table] Class of Warrant or Right [Table] Foreign Foreign Tax Jurisdiction [Member] Einstein License License Agreement For Patent Rights [Member] License agreement for patent rights. Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Agreed To Increase Full Time Employee Salaries Agreed To Increase Full Time Employee Salaries Agreed To Increase Full Time Employee Salaries Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Long-Term Debt, Gross Total maturities Total maturities Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Total property and equipment Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, plant and equipment, gross Property, Plant and Equipment, Gross Class Of Warrants Or Rights Cash Issue Exercises Class Of Warrants Or Rights Cash Issue Exercises Issued via cash exercise Issued via cash exercises Depreciation Amortization Of Trademark Amortization of trademark. Amortization of trademark Counterparty Name Counterparty Name [Axis] Tranche A loan [Member] Tranche A loan [Member] weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Investment Owned, Cost Carrying value of the investment Signapore Foreign Withholding Tax Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Signapore Foreign Withholding Tax Issuance of common stock upon exercise of warrants, net, Shares Issuance of common stock upon exercise of warrants, net, Shares Issuance of common stock upon exercise of warrants and pre-funded warrants, net, Shares Common stock warrant purchases common shares Common stock warrant purchases common shares Common stock warrant purchases common shares Issuance of common stock upon exercise of warrants, net, Amount Issuance of common stock upon exercise of warrants, net, Amount Issuance of common stock upon exercise of warrants and pre-funded warrants, net, Amount Interest Paid, Excluding Capitalized Interest, Operating Activity Cash paid for interest Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statistical Measurement Statistical Measurement [Domain] Exercise price of common stock warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Weighted average exercise price Total current assets Assets, Current Stock-based compensation Share-Based Payment Arrangement, Expense Two Thousand Twenty Four Pre Funded Warrants [Member] Two thousand twenty four pre funded warrants. 2024 Pre-funded warrants [Member] Document Period End Date Document Period End Date Equity Method Investments and Joint Ventures [Abstract] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax, Total Unrealized gains from available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Additional amount receivable research development regulatory and sales milestones Additional Amount Receivable Research Development Regulatory And Sales Milestones Additional amount receivable research development regulatory and sales milestones. Stock options exercisable Number of Shares, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Summary of Common Stock Warrant Activity Schedule Of Common Stock Warrants Activity Table [Text Block] Schedule Of Common Stock Warrants Activity Table Text Block. Gain (loss) on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Total Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Weighted average contractual life Statement of Financial Position [Abstract] Restricted Stock Units Restricted Stock Units (RSUs) [Member] Revenue Recognition Revenue [Policy Text Block] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] License agreement entered date License Agreement Entered Date License agreement entered date. Additional Laboratory Lease Second Amendment Additional Laboratory Lease Second Amendment [Member] Additional Laboratory Lease Second Amendment [Member] Cue Biopharma 401(k) Plan Compensation and Employee Benefit Plans [Text Block] Cybersecurity Risk Management, Strategy, and Governance [Line Items] Revenue recognized at a point in time Collaboration Revenue Recognized at a Point in Time Collaboration Revenue Recognized at a Point in Time Total liabilities Liabilities Financial Instruments Financial Instruments [Domain] Option pricing model [Member] Valuation Technique, Option Pricing Model [Member] Cash paid for amounts included in the measurement of lease liabilities: Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract] Cash paid for amounts included in measurement of lease liabilities. Equity Method Investments [Policy Text Block] Equity Method Investment Signapore Foreign Withholding Tax Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total Reserves and accruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Lessee, Operating Lease, Liability, to be Paid, Year Two 2027 Agreement 1 member. Sales Agreement June 2019 Agreement1 [Member] Pretax Loss Effective Income Tax Rate Reconciliation Income Tax Rate Pretax Loss Percent Effective Income Tax Rate Reconciliation Income Tax Rate Pretax Loss Percent Indefinite-Lived Intangible Assets, Major Class Name [Domain] Received Equity Percentage Received Equity Percentage Received equity percentage Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted average common shares outstanding, diluted Entity File Number Securities Act File Number Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary of significant accounting policies. Cover [Abstract] Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Exercise Price of Pre-Funded Warrant Exercise Price of Pre-Funded Warrant Exercise Price of Pre-Fund warrant Prepaid expenses and other short-term assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Percentage of number of common stock outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Cost, Direct Tax and License License Expense SINGAPORE Singapore [Member] U.S. Treasury Securities US Treasury Securities [Member] Number of shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Sale of Stock [Domain] Segment Reporting Disclosure [Text Block] Segment Information General and Administrative Expense, Total General and administrative General and Administrative Expense General and administrative Increase Decrease In Research And Development Contract Liability Increase (decrease) in research and development contract liability. Research and development contract liability, current portion Fair value assets transfers between Level 2 and Level 3 Fair Value Assets Among Level2 And Level3 Transfers Amount Fair value assets among level 2 and level 3 transfers amount. Subsequent Event [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Issued Other Deferred Tax Assets, Other Stock Issued During Period, Shares, Other Issuance of common stock and pre-funded warrants, net of issuance costs (In Shares) Adjustments to Additional Paid in Capital, Warrant Issued Additional Paid In Capital Warrant Issued Laboratory And Office Lease Laboratory And Office Lease [Member] Laboratory and office Lease. Deposits, current portion Deposits Assets, Current Short-term research and development contract liability Research And Development Contract Liability Current Research and development contract liability, current. Research and development contract liability, current portion Estimated useful lives Property, Plant and Equipment, Useful Life Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Future Minimum Lease Payments for Operating Lease Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Withheld as payment to cover issued shares Class Of Warrant Or Right Number Of Securities Withheld Class Of Warrant Or Right Number Of Securities Withheld. Withheld to cover issued shares Ono Collaboration and Option Agreement [Member] Ono Collaboration and Option Agreement [Member] Collaboration and Option Agreement with Ono Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Effective Income Tax Rate Reconciliation, Amount Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] Depreciation Total Depreciation Total Depreciation expense Depreciation Contract research services Accrued Contract Research Services Current Accrued contract research services current. Lease term Lessee, Operating Lease, Term of Contract Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding Operating Lease, Liability, Current Operating lease liabilities, net of current portion Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Cybersecurity Risk Management Processes Integrated [Flag] Document Transition Report Document Transition Report Omnibus Plan Omnibus Plan [Member] Omnibus plan member Research and other credits Deferred Tax Assets Tax Credit Carryforwards Research And Other Deferred tax assets tax credit carryforwards research and other. Net deferred tax assets Deferred Tax Assets, Net Total operating expenses Operating Expenses Accrued Liabilities, Current [Abstract] Research and Development Expense, Total Research and development Research and Development Expense Research and development Research and development expense Asset Impairment Charges Asset Impairment Charges, Total Impairment charges Leases Lessee, Operating Leases [Text Block] Tax Credit Indefinite Carryforward Amount Tax Credit Indefinite Carryforward Amount Tax Credit Indefinite Carryforward Amount Statement of Cash Flows [Abstract] Issuance of common stock from public offerings, net of underwriter commissions and fees Stock Issued During Period, Value, New Issues Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Stock-based compensation Stock-based compensation Stockholders' Equity Equity [Text Block] Amortization of capitalized license expense Amortization Of Capitalized License Expense Amortization of capitalized license expense. Other Deferred Tax Liabilities, Other Computer Equipment Computer Equipment [Member] Cybersecurity Risk Management Processes Integrated [Text Block] Net loss Warrant Issued June Fifteen Two Thousand Fifteen Member Warrant Issued June Fifteen Two Thousand Fifteen [Member] Warrant Issued June 15, 2015 Operating lease cost Operating Lease, Cost Common stock warrants life Warrants and Rights Outstanding, Term Weighted average contract remaining life (in years) Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Line of Credit Facility [Line Items] Operating cash flows from operating leases Operating cash flows from operating leases Operating Lease, Payments 2024 Pre-Funded Warrants Two Thousand Twenty Four Pre-Funded Warrants [Member] Two Thousand Twenty Four Pre-Funded Warrants [Member] ASSETS Assets [Abstract] Fair Value Assets Among Level1 AndLevel2 Transfers Amount Fair Value Assets Among Level1 AndLevel2 Transfers Amount Construction in Progress Construction in Progress [Member] Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Percentage of Loss and Gain Percentage of Loss and Gain Percentage of Loss and Gain Operating lease liability Increase Decrease In Operating Lease Liabilities Increase decrease in operating lease liabilities. Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Retirement Benefits [Abstract] Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Office space for lease Land Subject to Ground Leases Research and Development Research and Development Expense [Member] Acounts payable fees Accounts Payable Fees Accounts Payable Fees Marketable Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Research Tax Credit Research Tax Credit Carryforward [Member] Decrease in the carrying amount of right-of-use assets Change In Operating Lease Right Of Use Asset Change in operating lease right-of-use asset. Payment of term loan Payment of term loan Repayment of term loans Disposals of property and equipment Property, Plant and Equipment, Disposals First Research Term Processed Milestone Payment Under Agreement First Research Term Processed Milestone Payment Under Agreement First Research Term Processed Milestone Payment Under Agreement Proceeds from Stock Options Exercised Aggregate net processed Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Lessee, Operating Lease, Liability, to be Paid, Year One 2026 Accretion of final payment on term loan Accretion of final payment on term loan Accretion of final payment of term loan Sale of Stock, Consideration Received on Transaction Proceeds from common stock issuance transaction costs Effective Income Tax Rate Reconciliation [Line Items] Two Thousand Twenty Four Common Stock Warrants And Two Thousand Twenty Four Pre-Funded Warrants [Member] Two Thousand Twenty Four Common Stock Warrants And Two Thousand Twenty Four Pre-Funded Warrants [Member] 2024 Pre-Funded Warrants and 2024 Common Stock Warrants Debt Instrument [Axis] Derivative Instrument Derivative Instrument [Axis] Share-Based Payment Arrangement [Abstract] Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized stock-based compensation Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Assets, Fair Value Disclosure Cash equivalents and marketable securities Cash equivalents and marketable securities Sale of Stock [Axis] Success-based research, development and commercial milestone payments Success-based Research, Development and Commercial Milestone Payments Success-based Research, Development and Commercial Milestone Payments Schedule of Nonvested Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Equity Method Investments and Joint Ventures Disclosure [Text Block] Equity Method Investment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash provided by investing activities Private Placement [Member] Private Placement Common Stock Options Common Stock Options [Member] Common stock options. Issuance of common stock from ATM offering, net of sales agent commission and fees, Amount Issuance of common stock from ATM offering, net of sales agent commission and fees, Amount Title of 12(b) Security Title of 12(b) Security Deferred tax liability: Deferred Tax Liabilities, Net [Abstract] Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Stock-based compensation Income Tax Paid, by Individual Jurisdiction [Table] Weighted Average Exercise Price, Cancelled Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Payments For Redemption Of Short Term Investments Payments for redemption of short term investments. Redemption of marketable securities Related and Nonrelated Parties [Domain] Proceed From Pre Funded Warrants Financing Proceed From Pre Funded Warrants Financing Proceed From Pre Funded Warrants Financing Disposal of property and equipment, gross Property Plant And Equipment Disposal Gross Property plant and equipment disposal gross. Income Taxes Income Tax Disclosure [Text Block] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Shares Acquired, Weighted Average Discount to Net Assets, Percentage Percent of ordinary shares Class Of Warrant Or Right [Line Items] Class of Warrant or Right [Line Items] Schedule Of Future Minimum Rental Payment For Operating Leases [Table Text Block] Schedule Of Future Minimum Rental Payment For Operating Leases [Table Text Block] Schedule of Future Minimum Lease Payments for Operating Lease Albert Einstein College Of Medicine Albert Einstein College Of Medicine [Member] Albert Einstein College of Medicine. Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Property, Plant and Equipment [Table Text Block] Summary of Property and Equipment Weighted Average Exercise Price, Outstanding Beginning Balance Weighted Average Exercise Price, Outstanding Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Warrants Issued September Two Thousand Twenty Four [Member] Warrants Issued September Two Thousand Twenty Four [Member] Warrants Issued September, 2024 [Member] Income Tax Disclosure [Abstract] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Unrecognized tax benefits Balance at the beginning of year Balance as of end of year Unrecognized Tax Benefits Additional Paid-in Capital Additional Paid-in Capital [Member] Collaboration Agreement with Merck Collaboration Agreement With Merck [Member] Collaboration agreement with merck. Issued via cashless exercises Class Of Warrants Or Rights Cashless Issue Exercises Class of warrants or rights cashless issue exercises. Issued via cashless exercise HC Wainwright & Co LLC [Member] HC Wainwright & Co LLC [Member] HC Wainwright & Co LLC [Member] Measurement Frequency Measurement Frequency [Domain] Income Statement Location Statement of Income Location, Balance [Axis] Trading Symbol Trading Symbol Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Security Deposit Liability Security Deposit Liability Lease extended date Lease Extended Date Lease extended date. Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Subsequent Event Type [Axis] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Lease Cash Collected Lease Cash Collected Expected life Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax Loss before provision for income taxes Loss before provision for income taxes Loss before provision for income taxes Fair Value Measurements, Recurring Basis Fair Value, Recurring [Member] Entity Ex Transition Period Entity Ex Transition Period Schedule of Equity Method Investments [Line Items] Total lease payments Lessee, Operating Lease, Liability, to be Paid Less: present value discount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Federal R&D Credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Federal R&D credit Development and commercial milestone payment payable cuo biopharma Development and commercial milestone payment payable cuo biopharma Development and commercial milestone payment payable cuo biopharma ImmunoScape Collaboration and License Agreement [Member] ImmunoScape Collaboration and License Agreement [Member] ImmunoScape Collaboration and License Agreement Equity Components Equity Components [Axis] Adjustment related to lease liability Adjustment Related To Lease Liability Adjustment related to lease liability Milestone payments for each product, process or service Aggregate Amount Of Milestone Payments For Each Product Process Or Service Maximum The maximum aggregate amount of milestone payments for each product, process or service. Schedule of Collaboration revenue Schedule of Collaboration Revenue [Table TextBlock] Schedule of Collaboration Revenue [Table TextBlock] Nonoperating Income (Expense) Total other income, net Equity Component Equity Component [Domain] Option Time Based Payment Option Time Based Payment Option Time Based Payment Lease Liabilities Arising From Obtaining Right of Use Assets Lease Liabilities Arising From Obtaining Right of Use Assets Lease liabilities arising from obtaining right-of-use assets License monthly rental rate third year License monthly rental rate third year License monthly rental rate third year Additional Time Based Payment Additional Time Based Payment Additional Time Based Payment On November Sixteen Two Thousand Twenty Two [Member] On November Sixteen Two Thousand Twenty Two [Member] On November 16, 2022 [Member] Common Stock Warrants [Member] Common Stock Warrants [Member] Common Stock Warrants Document Annual Report Document Annual Report Reduction to right-of-use asset Increase Decrease In Right Of Use Assets Increase decrease in right of use assets. Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Class Of Pre Funded Warrant Or Right Outstanding Class Of Pre Funded Warrant Or Right Outstanding Outstanding pre-funded warrants at December 31, 2025 Maximum Maximum [Member] Two Thousand Twenty Five Stock Incentive Plan [Member] Two Thousand Twenty Five Stock Incentive Plan [Member] 2025 Stock Incentive Plan Statistical Measurement Statistical Measurement [Axis] Weighted Average Exercise Price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Common stock, $0.001 par value; 300,000,000 and 200,000,000 shares authorized at December 31, 2025 and December 31, 2024, respectively; 96,621,218 and 61,819,101 shares issued and outstanding at December 31, 2025 and 2024, respectively Other Long-Term Debt, Current Current portion of long-term debt, net Current portion of long-term debt, net Consolidation Consolidation, Policy [Policy Text Block] Laboratory Equipment Equipment [Member] Proceeds from Sale of Furniture and Fixtures Cash collected from sale of assets Deferred Tax Assets, Operating Loss Carryforwards, Total Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Tax Credit Carryforward Tax Credit Carryforward [Axis] Debt Instrument Final Fee Debt Instrument Final Fee Debt Instrument Final Fee Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State taxes State taxes Amortization of Debt Issuance Costs Amortization of debt issuance costs Pre Funded Warrants Pre Funded Warrants Pre Funded Warrants Pre-Funded Warrants [Member] Entity Public Float Entity Public Float Two Thousand Twenty Five Pre-Funded Warrants One [Member] Two Thousand Twenty Five Pre-Funded Warrants One [Member] 2025 Pre-Funded Warrants One Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and contingencies Preferred stock, shares authorized Preferred Stock, Shares Authorized Securities Financing Transaction Securities Financing Transaction [Domain] Lender Name [Axis] Accounts Payable and Other Accrued Liabilities Accrued Liability Collaboration Revenue Revenue from Contract with Customer [Text Block] Entity Registrant Name Entity Registrant Name Debt Disclosure [Text Block] Loan with Silicon Valley Bank, a Division of First Citizens Bank Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Entity Voluntary Filers Entity Voluntary Filers Purchase of additional shares of common stock. Purchase of Additional Shares Of Common Stock Purchase of Additional Shares Of Common Stock Subsequent Events [Abstract] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Income Tax Expense (Benefit), Total Provision for income taxes Income Tax Expense (Benefit) Tax provision related to foreign withholding tax Provision for income taxes Underwriting Agreement [Member] Underwriting Agreement [Member] Underwriting Agreement Total Collaboration Revenue Total Collaboration Revenue Total collaboration revenue Measurement Frequency Measurement Frequency [Axis] Einstein License And Service Agreement Einstein License And Service Agreement [Member] Einstein license and service agreement. Proceeds from Issuance of Common Stock Proceeds from common stock issuance, net of transaction costs Proceeds from issuance of common stock, warrants and pre-funded warrants, net of transaction costs Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Lessee, Operating lease, Increase in monthly rental payments Lessee, Operating lease, Increase in monthly rental payments Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Common Stock Warrant at a combined offering price Common Stock Warrant at a combined offering price Common Stock Warrant at a combined offering price Total assets Assets Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Income Tax Paid, State Income Tax Paid, State and Local, after Refund Received Income Tax Paid, State and Local, after Refund Received, Total Weighted Average Remaining Contractual Life (in Years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Option exercisable period Income Statement [Abstract] Retirement Plan Name Retirement Plan Name [Domain] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Reductions of prior year tax provisions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Warrants purchase shares of common stock Warrants purchase shares of common stock Warrants purchase shares of common stock Sale of Stock, Number of Shares Issued in Transaction Sale of common stock, number of shares Schedule Of Income Taxes Paid Net Of Refunds Received [Table Text Block] Schedule of Income Taxes Paid Net Of Refunds Received [Table Text Block] Schedule of Company's income taxes paid (net of refunds received) Shares of common stock Issuance of common stock from public offerings, net of underwriter discounts, Shares Stock Issued During Period, Shares, New Issues Number of Shares, Vested/Released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Net loss per common share - diluted Premium paid for stock purchased Premium Paid For Stock Purchased Premium paid for stock purchased. Proceeds from At the time market offering net of commission and fees. Proceeds From At Time Market Offering Net Of Commission And Fees Proceeds from ATM offering, net of sales agent commission and fees Effective Income Tax Rate Reconciliation, Percent [Abstract] Effective Income Tax Rate Reconciliation, Percent Cash obligation Cash Obligation Cash obligation City Area Code City Area Code Debt Instrument, Convertible, Conversion Date Debt Instrument, Convertible, Conversion Date Auditor Name Restricted Cash and Cash Equivalents, Current, Total Short-term restricted cash Restricted Cash and Cash Equivalent, Current Pre-Funded Warrant Offer Price Pre-Funded Warrant Offer Price Pre-Funded Warrant Offer Price Number of supporting technology Number Of Supporting Technology Number ff supporting technology. Collaboration Agreement with LG Chem Life Sciences Collaboration Agreement With L G Chem Life Sciences [Member] Collaboration agreement with LG Chem Life Sciences. Debt Instrument, Face Amount Debt issuance costs Patent Expenses Intangible Assets, Finite-Lived, Policy [Policy Text Block] Counterparty Name Counterparty Name [Domain] Federal R&D Credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Federal R&D credit License monthly rental rate remainder of the term License monthly rental rate remainder of the term License monthly rental rate remainder of the term License Monthly Rental Partial Credit License Monthly Rent Partial Credit License monthly rental partial credit Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term (years) Stock Issued During Period, Shares, Restricted Stock Award, Gross Restricted stock award, Shares Investor [Member] Lease expiration date Lease Expiration Date License Agreement Terms [Member] License Agreement Terms [Member] Lessee operating lease monthly rental rate Lessee Operating Lease Monthly Rental Payments For First Eighteen Months Lessee operating lease monthly rental payments for first eighteen months. Retirement Plan Name Retirement Plan Name [Axis] Award Date Award Date [Axis] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Property and equipment, net Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property and equipment, net Property, Plant and Equipment, Net License monthly rental rate first year License monthly rental rate first year License monthly rental rate first year Revenue recognized over time Collaboration Revenue Recognized Over Time Collaboration Revenue Recognized Over Time Two Thousand Twenty Two Pre Funded Warrants [Member] Two Thousand Twenty Two Pre Funded Warrants [Member] 2022 Pre-funded warrants [Member] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash, cash equivalents, and restricted cash at beginning of year Cash, cash equivalents, and restricted cash at end of year Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Loss from operations Operating Income (Loss) Award Date Award Date [Domain] Additional Received Upfront Payments Additional Received Upfront Payments Stifel Nicolaus And Company Incorporated Member Stifel Nicolaus and Company Inc. Stifel Nicolaus And Company Incorporated [Member] Accumulated Deficit Retained Earnings [Member] Two Thousand Twenty Two Common Stock Warrants [Member] Two Thousand Twenty Two Common Stock Warrants [Member] 2022 Common Stock Warrants Share-based Payment Arrangement, Noncash Expense, Total Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Long-Term Debt and Lease Obligation, Total Long-Term Debt and Lease Obligation Long term operating lease obligations Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Liability, Noncurrent Operating lease liabilities, current portion On April Fourteen Two Thousand Twenty Five [Member] On April Fourteen Two Thousand Twenty Five [Member] On April 14, 2025 [Member] Level 1 Fair Value, Inputs, Level 1 [Member] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Lease, Cost [Table Text Block] Schedule of Weighted Average Remaining Lease Term and Discount Rate Nontaxable or Nondeductible Items: Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent [Abstract] Sale Leaseback Transaction, Transaction Costs, Financing Activities Proceeds from prefunded-warrant issuance, Net transaction costs Auditor Location Warrant Issued November Sixteen Two Thousand Twenty Two Member Warrant Issued November Sixteen Two Thousand Twenty Two [Member] Warrant Issued November 16, 2022 Deposits Assets, Noncurrent Deposits, net of current portion Income Taxes [Line Items] Income Taxes [Line Items] Income taxes. Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Number of Warrants Outstanding Nonoperating Income (Expense) [Abstract] Other income (expense): Derivative Contract Derivative Contract [Domain] Loss (gain) on fixed asset disposal and right-of-use asset termination Gain on right-of-use asset termination Gain On Right Of Use Asset Termination Gain On Right Of Use Asset Termination Accounting Pronouncements Adopted AccountingPronouncementsAdoptedPolicyTextBlock AccountingPronouncementsAdoptedPolicyTextBlock Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Income Tax Authority Income Tax Jurisdiction [Domain] Debt Securities Available For Sale [Table] Debt Securities, Available-for-Sale [Table] Entity Interactive Data Current Entity Interactive Data Current Income Statement Location Statement of Income Location, Balance [Domain] Other Income Other Income [Member] Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Furniture and Fixtures Furniture and Fixtures [Member] Forty G office and additional laboratory. Forty G Office and Additional Laboratory [Member] Issuance of Securities through a Private Placement PrivatePlacementPolicyTextBlock PrivatePlacementPolicyTextBlock Amended Lease Agreement Amended Lease Agreement [Member] Amended lease agreement. Entity Tax Identification Number Entity Tax Identification Number Accretion of final payment Accretion of final payment Accretion of final payment Long-Term Debt, Type [Axis] Placement Agent Fees And Offering Expenses Placement Agent Fees And Offering Expenses Offering Expenses Local Phone Number Local Phone Number Related Party Transaction [Domain] Class Of Pre Funded Warrant Or Right Exercise Price Of Warrants Or Rights 1 Class Of Pre Funded Warrant Or Right Exercise Price Of Warrants Or Rights 1 Weighted average exercise price of pre-funded warrants at December 31, 2025 Auditor Opinion [Text Block] Auditor Opinion Monthly installments Monthly Installments Monthly Installments On September 26, 2024 [Member] On September Twenty Six Two Thousand Twenty Four [Member] On September Twenty Six Two Thousand Twenty Four [Member] Trademarks Trademarks [Member] Accounting Policies [Abstract] Disaggregation Of Revenue [Line Items] Disaggregation of Revenue [Line Items] BI Collaboration and License Agreement BI Collaboration and License Agreement [Member] BI Collaboration and License Agreement [Member] Revenue from Contract with Customer, Excluding Assessed Tax, Total Collaboration revenue Revenue from Contract with Customer, Excluding Assessed Tax Restricted stock awards released, Shares Repurchase of restricted stock awards, Shares Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Decrease In Lease Liability Increase Decrease In Lease Liability Increase decrease in lease liability. Professional services Accrued Professional Fees, Current Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-Lived Intangible Assets [Axis] Loss on Right Of Use Asset Gain Loss On Right Of Use Asset Gain and loss on right of use asset. Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain]